In a 13G filing on Peregrine Pharmaceuticals (NASDAQ: PPHM), hedge fund Ayer Capital Management disclosed a 5.51%, or 3,743,030 share, stake in the company. The firm held calls options representing 2 million shares at the end of the latest quarter ending September 30, 2012.

For more notable holders of PEREGRINE PHARMA stock click here. For more information on Ayer Capital Management click here.

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW